Shuttle Pharmaceuticals Holdings, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.44; its P/E ratio is -0.95; Shuttle Pharmaceuticals Holdings, Inc. is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -1.24M	$ -903.31K	$ -1.05M	-	$ -379.98K
EBITDA	$ -696.79K	$ -352.70K	$ -484.12K	-	$ -362.99K
Net Income Common Stockholders	$ -1.79M	$ -2.18M	$ 1.48M	-	$ -1.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 6.81M	$ 8.35M	$ 10.16M	$ 8.42M	$ 9.12M
Total Assets	$ 7.38M	$ 8.84M	$ 10.44M	$ 8.65M	$ 9.38M
Total Debt	$ 503.84K	$ 513.12K	$ 935.55K	$ 748.30K	$ 765.85K
Net Debt	$ -6.30M	$ -7.84M	$ -9.23M	$ -7.67M	$ -8.35M
Total Liabilities	$ 1.77M	$ 1.90M	$ 3.53M	$ 975.68K	$ 977.14K
Stockholders Equity	$ 5.61M	$ 6.94M	$ 6.91M	$ 7.68M	$ 8.40M
Cash Flow	-
Free Cash Flow	$ -1.55M	$ -1.65M	$ -1.34M	$ -679.87K	$ -1.05M
Operating Cash Flow	$ -1.53M	$ -1.65M	$ -1.34M	$ -679.87K	$ -1.05M
Investing Cash Flow	$ -25.86K	$ 62.80K	$ -2.95M	-	$ 0.00
Financing Cash Flow	-	$ -139.23K	$ 3.04M	$ -23.32K	$ 10.12M

Currency in USD

Shuttle Pharmaceuticals Holdings, Inc. Earnings and Revenue History

Income Statement >

Shuttle Pharmaceuticals Holdings, Inc. Debt to Assets

Balance Sheet >

Shuttle Pharmaceuticals Holdings, Inc. Cash Flow

Cash Flow >

Shuttle Pharmaceuticals Holdings, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing